• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • JP

      JP

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    • Marcel R. Wernard, Netherlands

      Marcel R. Wernard, Netherlands

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • Olga Cosentino, Argentina

      Olga Cosentino, Argentina

    • Chen Yin Xue, Taiwan

      Chen Yin Xue, Taiwan

    • Karl Hughes, Ireland

      Karl Hughes, Ireland

    • Yessenia Hernandez Mendoza, Mexico

      Yessenia Hernandez Mendoza, Mexico

    • Irene McCaughey, Australia

      Irene McCaughey, Australia

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • Dr. Shelly Hoover, USA

      Dr. Shelly Hoover, USA

    • Rudiger Hanemann, Germany

      Rudiger Hanemann, Germany

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Hollister

      Hollister
      hollister

    • Manuel Arn, Switzerland

      Manuel Arn, Switzerland

    • Ian Roberts, Australia

      Ian Roberts, Australia

    • Maria Lucia Wood Saldanha, Brazil

      Maria Lucia Wood Saldanha, Brazil

    • Eddy Lefrancois, Canada

      Eddy Lefrancois, Canada

    • Tso-Ta Huang, Taiwan

      Tso-Ta Huang, Taiwan

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Vincent Bourque, Canada

      Vincent Bourque, Canada
      vincent_bourque

    • Steve Lufkin, USA

      Steve Lufkin, USA
      IMG_3993

    • Gisli Jonasson, Iceland

      Gisli Jonasson, Iceland

    • Denis Blais, Canada

      Denis Blais, Canada

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Animesh Kumar, India

      Animesh Kumar, India

    • Federica Mastrosimone, Italy

      Federica Mastrosimone, Italy

    • Zabun Nassar, England

      Zabun Nassar, England

    • Frank Bos, Netherlands

      Frank Bos, Netherlands

    • Jon Newsome, USA

      Jon Newsome, USA

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Ismail Gokcek, Turkey

      Ismail Gokcek, Turkey
      ismail_gokcek_alsmnd_tr

    • Duncan Bayly, Australia

      Duncan Bayly, Australia

    • Den Haag, Netherlands

      Den Haag, Netherlands

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Jay Epstein, USA

      Jay Epstein, USA

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Ian Gale, Australia

      Ian Gale, Australia

    • Ywan Dierick, Belgium

      Ywan Dierick, Belgium

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Diana Fernandez, Argentina

      Diana Fernandez, Argentina

    • Verónica Isabel Castro Molina, Argentina

      Verónica Isabel Castro Molina, Argentina

    • Mahmood Anwar, UK

      Mahmood Anwar, UK

    • Peng Yi-Wen, Taiwan

      Peng Yi-Wen, Taiwan

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login